Search Results - "Sousa, D. Rangel"

Prognostic Value of Blood Panel Parameters in Patients With Dilated Cardiomyopathy and Advanced Heart Failure by Sobrino-Márquez, J.M., Grande-Trillo, A., Cantero-Pérez, E.M., Rangel-Sousa, D., Lage-Galle, E., Adsuar-Gómez, A.

“…Patients with dilated cardiomyopathy (DCM) and left ventricular dysfunction have a varied clinical course, not only dependent on left ventricular ejection…”
Get full text

Complex Congenital Heart Disease: Is Heart Transplantation an Option? by Esteve-Ruiz, I., Grande-Trillo, A., Rangel-Sousa, D., Adsuar-Gómez, A., Sobrino-Márquez, M., Lage-Gallé, E.

“…Within the heart transplant (HT) population, few patients have complex congenital heart disease (CHD) underlying disease. Our objective is to assess the…”
Get full text

Preoperative Cardiac Assessment of Patients Undergoing Orthotopic Liver Transplantation: Experience in One Center by Grande-Trillo, A, Sobrino-Márquez, J.M, Escobedo-Mesas, E, Rangel-Sousa, D, López-Haldón, J.E, Lage-Gallé, E

“…Abstract Preoperative cardiac evaluation of patients undergoing liver transplantation is not well established. Stress testing is used in many centers, and…”
Get full text

Implantable Cardioverter Defibrillator for Primary Prevention in Patients with Severe Ventricular Dysfunction Awaiting Heart Transplantation by Cantero-Pérez, E.M, Sobrino-Márquez, J.M, Grande-Trillo, A, Lage-Gallé, E, Rangel-Sousa, D, Esteve-Ruiz, I.M, Martínez-Martínez, A

“…Abstract Background Despite an increase in patients with end-stage heart failure, the acceptance rate has been going down in recent years owing to a change in…”
Get full text

(278) Elevated Lipoprotein A Levels and Development of Moderate or Severe Cardiac Allograft Vasculopathy by Sousa, D. Rangel, Gonzalez-Quijano, M., Grande-Trillo, A., Esteve-Ruiz, I., Aranda-Dios, A., Sobrino-Márquez, J.

“…Elevated Lipoprotein (a) Lp(a) is an independent, genetic, and causal risk factor for cardiovascular disease.Knowledge regarding the role of Lp(a) levels in…”
Get full text

Donor-derived cell-free DNA kinetics in the first year post-transplant in patients without acute cellular rejection by Jimenez-Blanco Bravo, M, Crespo Leiro, M, Gonzalez Sardinero, E, Gomez Bueno, M, Lopez Villela, R, Ortiz Bautista, C, Farrero, M, Maestro Benedicto, A, Diaz Molina, B, Diez Lopez, C, Rangel Sousa, D, Salterain, N, Garrido Bravo, I, Segovia Cubero, J

Get full text

Role of NTproBNP and donor-derived cell-free DNA in the diagnosis of acute rejection in heart transplant recipients: a prospective study by Jimenez-Blanco Bravo, M, Crespo Leiro, M, Marco Clement, I, Lozano Jimenez, S, Donoso, V, Ortiz Bautista, C, Farrero, M, De Antonio, M, Diaz Molina, B, Diez Lopez, C, Rangel Sousa, D, Salterain, N, Garrido Bravo, I, Segovia Cubero, J

Get full text

Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study by Jimenez-Blanco Bravo, M, Crespo Leiro, M, Garcia Cosio, M D, Hernandez Perez, F J, Lopez Villela, R, Ortiz Bautista, C, Farrero, M, Zegri Reiriz, I, Diaz Molina, B, Diez Lopez, C, Rangel Sousa, D, Salterain, N, Garrido Bravo, I, Segovia Cubero, J

Get full text

First Case in Spanish Heart Transplant Registry of Heart and Kidney Transplant Related to Fabry Disease by Domínguez-Cano, J.L., Rangel-Sousa, D., Grande-Trillo, A.D., Adsuar-Gómez, A., González-Roncero, F.M., Acosta-Martínez, J., López-Herrera, D., Borrego-Domínguez, J., Sobrino-Marquez, J.

“…Fabry disease (FD) is rare disease, due to an X-linked inborn error of glycosphingolipid catabolism resulting from deficient or absent activity of the…”
Get full text

(1010) Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant by Jimenez-Blanco Bravo, M., Crespo-Leiro, M., Garcia-Cosio, M., Perez-Gomez, L., Lopez-Vilella, R., Ortiz Bautista, C., Farrero Torres, M., Benedicto, A. Maestro, Molina, B. Diaz, Diez-Lopez, C., Sousa, D. Rangel, Salterain, N., Bravo, I. Garrido, Segovia-Cubero, J.

“…Donor-derived cell-free DNA (dd-cfDNA) has shown a good ability to rule out acute cellular rejection (ACR) in heart transplant (HT) recipients, and is thus a…”
Get full text

(1006) Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study) by Jimenez-Blanco Bravo, M., Crespo-Leiro, M., Garcia-Cosio, M., Perez-Gomez, L., Lopez-Vilella, R., Ortiz Bautista, C., Farrero Torres, M., Maestro Benedicto, A., Diaz Molina, B., Diez-Lopez, C., Rangel Sousa, D., Salterain, N., Garrido Bravo, I., Segovia-Cubero, J.

“…There is a clear need for a non-invasive biomarker that could allow surveillance of acute cellular rejection (ACR) without the need of repeated endomyocardial…”
Get full text

5163Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene by Akhtar, M, Rangel-Sousa, D, Palomino-Doza, J, Arana Achaga, X, Bilinska, Z, Zamarreno Golvano, E, Climent, V, Navarro Penalver, M, Barriales-Villa, R, Charron, P, Yotti, R, Zorio, E, Jimenez-Jaimez, J, Garcia-Pavia, P, Elliott, P M

“…Abstract Background Truncating variants in Filamin C (FLNCtv) are associated with arrhythmogenic (AC) and dilated cardiomyopathies (DCM). Affected patients are…”
Get full text

P3169Clinical characteristics and natural history of dilated cardiomyopathy due to BAG3 mutations by Dominguez Rodriguez, F, Cuenca, S, Bilinska, Z, Toro, R, Charron, P, Barriales-Villa, R, Asselbergs, F, Akhtar, M, Morris Hey, T, Rangel-Sousa, D, Limeres, J M, Garcia-Pinilla, J M, Ochoa, J P, Elliott, P, Garcia-Pavia, P

Get full text

Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study by González-Vílchez, Francisco, Delgado, Juan F., Palomo, Jesús, Mirabet, Sonia, Díaz-Molina, Beatriz, Almenar, Luis, Arizón, José M., Rangel-Sousa, Diego, Pérez-Villa, Félix, Garrido, Iris P., de la Fuente, Luis, Gómez-Bueno, Manuel, Sanz, María L., Crespo-Leiro, María G.

“…Lifelong adherence with post-transplant immunosuppression is challenging, with nonadherence associated with greater acute rejection (AR) risk. This…”
Get full text

Prognostic Role of CA-125 in Patients Undergoing Cardiac Transplantation: Abstract# 1509 by Becerra-Munoz, V., Sobrino-Marquez, J., Rangel-Sousa, D., Fernandez-Cisnal, A., Lage-Galle, E., Martinez-Martinez, A., deTeresa-Galvan, E.

Get full text